“We expect to work with the FDA over the coming weeks in an effort to address the open issues and to define a path forward for a successful re-filing of our application at the earliest point in time,” said Tony Zook, CEO of Innocoll. In May, 2016, the Company had announced that two placebo-controlled Phase 3 pivotal studies evaluating XARACOLL (bupivacaine-collagen bioresorbable implant) each achieved the primary endpoint as a postoperative pain relief treatment immediately following open abdominal hernia repair. XARACOLL showed consistency across both studies in treatment effect for pain reduction and opioid reduction. Second Setback The FDA refusal is a second setback for Innocoll in recent months. On November 03, 2016, Innocoll announced that based on top-line data from its COACT-1 and http://www.tahlequahdailypress.com/sports/thunder-pg-payne-undergoes-foot-surgery/article_5278b1ec-a018-5f1e-8f45-003d0c6339c8.html COACT-2 Phase 3 clinical trials of COGENZIA (gentamicin collagen topical matrix) in patients with moderate to severe diabetic foot infections administered in conjunction with systemic antibiotics and wound therapy, the standard of care (SOC), did not meet their primary endpoint of clinical cure of infection after 28 days versus either placebo plus SOC or SOC alone. Stock Performance On Friday, December 30, 2016, following the announcement, Innocoll Holdings’ shares nosedived 61.02%, finishing the day at $0.69. A total volume of 7.83 million shares exchanged hands by the close of the trading session, which was significantly higher than its 3 months average volume of 90.40 thousand shares. The stock currently has a market cap of $53.30 million. Active Wall Street: Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps.Dane Swan Collingwood: More surgery needed for Magpie star | Herald Sun
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/blog-coverage-innocoll-received-fda-131500854.html
Autonomic neuropathy results in dry, stiff, cracked skin and painful calluses. Metatarsalgia treatment includes use of painkiller medications and using arch support. The other common cause of burning feet is chronic alcoholism. Infections of the soft tissues of the foot are called cellulitis. Ganglion Cyst: Ganglion cyst is a spongy to firm lump on top of the foot that may or may not freely move. Careful examination, MRI, X-ray, etc., help diagnose the problem. After around 5 minutes, when the cramp was finally gone, I was able to sleep peacefully. Peripheral artery disease is a medical condition that is caused by atherosclerosis, which refers to the narrowing of the peripheral arteries that carry oxygenated blood to the limbs due to the build-up of plaque.